ABL2 (1q25.2) BA

Intended Use
The ABL2 gene has been initially identified as a novel fusion partner of ETV6. ABL2 belongs to the Abelson family of non-receptor tyrosine kinases and is highly similar to ABL1. t(1;12)(q25;p13) results in a chimeric ETV6-ABL2 protein with a constitutive active tyrosine kinase.
Patient Preparation
  • Sample collection: Non-diluted bone marrow aspirate. Collect in a sodium heparinized Vacutainer.
  • Specimen preparation: Do not freeze or expose to extreme temperatures.
  • Bone Marrow: Transfer 3 mL bone marrow to a Green (Sodium Heparin). (Min: 1 mL)
  • Whole Blood: Transport 5 mL whole blood. (Min: 2 mL)
  • Storage/Transport Temperature: Room temperature.
  • Unacceptable Conditions: Frozen specimens. Clotted specimens.
  • Remarks:
  • Stability: Ambient: 48 hours; Refrigerated: 48 hours; Frozen: Unacceptable
Methodology

Fluorescence in situ Hybridization (FISH)

Sample received to report Turnaround time (TAT)

3 working days

Reference Interval

————-

Interpretive Data

The most recent WHO classification of Tumours of Hematopoietic and Lymphoid Tissues (Revised 5th edition) is used for interpretation criteria for evaluation.

Resources

Sample Reports